Physician profile
Simon G Rizk
NPI 1720092877
$15,743.66
in general payments reported to CMS, 2019-2025
34 companies · $1,640 in 2025
The $1,640 reported for 2025 was more than what 80% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,254 · 2020: $790 · 2021: $1,793 · 2022: $1,462 · 2023: $3,383 · 2024: $5,422 · 2025: $1,640.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $8,333 · Food and Beverage: $2,091 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $8,333.33 |
| Food and Beverage | $2,091.47 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $8,473.96 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Boston Scientific Corporation | $1,256.56 | 2019-2025 | Avvigo Guidance System, Ekosonic, General - Guidewires |
| Janssen Pharmaceuticals, INC | $834.74 | 2019-2022 | |
| Abiomed | $743.86 | 2020-2025 | Impella |
| Merck Sharp & Dohme LLC | $575.37 | 2021-2025 | Verquvo, Januvia |
| Astrazeneca Pharmaceuticals LP | $477.96 | 2020-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $343.95 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.24 | 2020-2025 | Jardiance |
| Abbott Laboratories | $277.25 | 2020-2025 | Aveir, Diamondback Coronary, Jot Dx |
| Medtronic, INC. | $242.21 | 2021-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Sanofi-Aventis U.S. LLC | $223.34 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $209.14 | 2019-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $205.44 | 2021-2023 | Nexletol |
| Medtronic Vascular, INC. | $197.96 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $195.00 | 2019-2023 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $186.38 | 2019-2025 | |
| Philips North America LLC | $149.53 | 2019-2021 | |
| Chiesi USA, INC. | $134.28 | 2020-2022 | |
| Amgen INC. | $91.46 | 2020-2022 | |
| Biotronik INC. | $86.60 | 2023-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Pamira |
| Bayer Healthcare Pharmaceuticals INC. | $71.77 | 2022-2024 | |
| Edwards Lifesciences Corporation | $65.38 | 2023 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $60.83 | 2022 | |
| Arbor Pharmaceuticals, INC. | $59.81 | 2019-2020 | |
| Lilly USA, LLC | $41.37 | 2019 | |
| Impulse Dynamics (USA) INC. | $34.28 | 2023 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $25.14 | 2024 | Arcalyst |
| Braemar Manufacturing, LLC | $23.97 | 2019 | |
| Stryker Corporation | $23.77 | 2021 | |
| Ekos Corporation | $21.74 | 2019 | |
| Penumbra, INC. | $20.00 | 2023 | Smart Coil |
| Cardiovascular Systems INC. | $19.48 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $17.90 | 2022 | |
| Novo Nordisk INC | $15.99 | 2024 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Rizk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.